Design, synthesis and pharmacological evaluation of hybrid molecules out of quinazolinimines and lipoic acid lead to highly potent and selective butyrylcholinesterase inhibitors with antioxidant properties.

Source:http://linkedlifedata.com/resource/pubmed/id/18343673

Bioorg. Med. Chem. 2008 Apr 15 16 8 4252-61

Download in:

View as

General Info

PMID
18343673